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Abstract 
 
Aspects of diagnosis and treatment of hypopituitarism in adult life 
 
Helena Filipsson 
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Sektionen för endokrinologi, Sahlgrenska Universitetssjukhuset, Göteborg 
 
Management of adult patients with hypopituitarism can improve with better charac-
terisation of idiopathic pituitary insufficiency (IPI) and clearer diagnosis of central hy-
pothyroidism (CH). Moreover, optimised treatment strategies for glucocorticoid (GC) 
replacement therapy and of long-term growth hormone (GH) in GH deficiency (GHD) 
are needed. 
This thesis contains four studies addressing these issues. By evaluating patients 
with IPI, mutations generating hypopituitarism were identified in an unselected adult 
IPI population. A new allel constellation in a compound PROP1 mutation was re-
vealed in two siblings, with a phenotype of very late inset ACTH-insufficiency. Those 
cases were only detected in patients with documented childhood-onset disease. A 
pilot study investigated the response of the thyroid gland after stimulation with 0.9 mg 
recombinant human thyreotropin (rhTSH) in patients with newly diagnosed CH and 
healthy controls. The untreated CH patients had lower free thyroxine response than 
controls. A database study containing 2424 hypopituitary patients, divided into ACTH 
insufficient and ACTH-sufficient (AS) patients, demonstrated a clear GC dose-re-
sponse relation with metabolic outcome. Patients with hydrocortisone equivalent 
doses of <20 mg/day had a similar metabolic profile as AS patients. In a large study 
on GHD patients on long-term GH treatment quality of life (QoL), body composition, 
and metabolic outcome were evaluated during 4-month-GH-discontinuation in a dou-
ble blind, placebo controlled design. QoL deteriorated, body composition moved 
towards a GHD state and metabolic parameters were impaired during placebo treat-
ment. 
These studies infer that genetic hypopituitarism should be searched for in IPI 
cases, especially in childhood onset disease and where there is a family history. The 
diagnosis of CH can be improved by an rhTSH test. In many cases, doses of GC can 
be reduced in ACTH-insufficient patients in order to improve their metabolic outcome 
and continuous long-term GH replacement is needed to maintain beneficial effects on 
QoL, body composition and metabolism.  
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